Evolving Minds By Pink Elephant

Pink Elephant Team
  • 0.0 (0)
  • ENTREPRENEURSHIP

The Evolving Minds Podcast, by Pink Elephant. Insightful conversations with the entrepreneurs, executives, and changemakers shaping the future of mental health and psychedelic medicine. From ambitious startups to established industry leaders, we spotlight the people and ideas behind the next generation of digital health, alternative therapies, and psychedelic ventures. Meet the Minds Changing the Business of Healing

Episodes

  1. Building the Future of BIOTECH, with Doug Drysdale, former CEO of Cybin (Helus Pharma)

    JAN 26

    Building the Future of BIOTECH, with Doug Drysdale, former CEO of Cybin (Helus Pharma)

    In this exclusive interview, veteran biotech executive Doug Drysdale sits down with Jason Najum from Pink Elephant to discuss the strategy that steered Cybin through the 'biotech winter.' Although Doug stepped down as CEO in September 2025 and the company has since rebranded to Helus Pharma, his insights reveal the critical data-driven decisions that allowed the company to survive and evolve when dozens of competitors failed. #Cybin #HelusPharma #Biotech #DougDrysdale #CNS #MentalHealthInnovation #Pharma In this conversation, Doug covers: — Why he left a 35-year career in traditional pharma after seeing psychedelics deliver "10 times the effect size" of standard drugs. — The reality of the "hype cycle": How the industry went from 90 companies to just a handful of survivors. — Why "Me Too" drugs failed and why you can't just run a science project — you need a commercial product. — The debate on short-acting trips: Why the frequency of treatments matters way more than how long the session lasts. — His contrarian take on AI: Why computers can't design these drugs yet (and why human chemistry is still winning). — The next frontier: Treating Parkinson's, MS, and the rise of non-hallucinogenic "psychedelic light" supplements. Timestamps: 00:00 Intro  00:41 35 Years in the Game  01:55 The Data That Changed His Mind (10x Effect)  05:12 When Bankers Said "No"  07:49 Killing the Supplement Division  12:07 Why You Can't Please Every Investor  18:46 The Great Industry Culling  23:15 "Science Projects" vs. Real Products  26:07 Do Short-Acting Trips Actually Matter?  31:46 Why AI Isn't Ready Yet  34:11 Neurodegeneration & "Psychedelic Light"  36:26 What's Next?  https://www.linkedin.com/in/dougdrysdale/  https://www.helus.com/ Like what you heard? Hit subscribe and follow us for more in-depth insights into the future of mental health -- @evolving_minds_podcast Stay tuned with our channels:  Spotify: https://open.spotify.com/show/0lOYS1R9bu7plbF65sbR5u Apple Podcast: https://podcasts.apple.com/us/podcast/evolving-minds-by-pink-elephant/id1829115616 LinkedIn: https://www.linkedin.com/company/pink-elephant-fund/ Twitter: https://x.com/PinkElephantHQ The Evolving Minds podcast by Pink Elephant, hosted by Jason Najum, is a series of 1-on-1 conversations with star guests who dare to build, scale, or rethink companies, policies, and protocols at the frontier of progressive mental health.

    34 min
  • 1 Episode

About

The Evolving Minds Podcast, by Pink Elephant. Insightful conversations with the entrepreneurs, executives, and changemakers shaping the future of mental health and psychedelic medicine. From ambitious startups to established industry leaders, we spotlight the people and ideas behind the next generation of digital health, alternative therapies, and psychedelic ventures. Meet the Minds Changing the Business of Healing

Information

  • Creator
    Pink Elephant Team
  • Years Active
    2025 - 2026
  • Episodes
    1
  • Rating
    Clean
  • Copyright
    © 2026 Evolving Minds By Pink Elephant